Clinical trial
A Study Evaluating the Safety and Efficacy of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in ASA III and IV Patients Undergoing Colonoscopy
NCT02532647 is registered in ClinicalTrials.gov with Paion UK Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study Evaluating the Safety and Efficacy of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in ASA III and IV Patients Undergoing Colonoscopy
- Lead sponsor
- Paion UK Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2015
- Completion date
- December 31, 2016
- Enrollment
- 79 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
colonoscopy